Eric Guempel, MBA ’95

Eric has been appointed by ImmunoGen, Inc., Eric-Guempela biotechnology company that develops targeted anticancer therapies using its antibody-drug conjugate technology, as the company’s vice president of product strategy and program management. In this role, Eric will ensure ImmunoGen advances its clinical compounds and implements development strategies that meet patient and market needs. He has over 30 years of experience in the healthcare industry, in particular in regards to the strategic development of oncology products. Prior to joining ImmunoGen, Eric served as head of new therapies and strategy for the oncology franchise at the Merck Serono division of Merck KGaA.

Eric Guempel, MBA ’95

Read About These Alumni:

Tagged on:         

Leave a Reply